Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 13, 2012Journal of Hematology & OncologyOpen Access

Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)

View Full Paper
Ask AI
Bookmark
Share

Authors

YKYu Ri KimYonsei UniversityJKJin Seok KimTokyo Institute of TechnologyYMYoo Hong MinYonsei University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kim et al. (2012) studied this question.

synapsesocial.com/papers/6aaca5b64df67298da93ceb2https://doi.org/10.1186/1756-8722-5-49
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1AJCC Cancer Staging Manual2010 · 6,056 citations
  2. 2A Predictive Model for Aggressive Non-Hodgkin's Lymphoma1993 · 5,015 citations
  3. 3Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.1989 · 1,641 citations
  4. 4Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma2008 · 698 citations
  5. 5Primary non-Hodgkin's lymphoma of bone. A clinicopathologic study1994 · 121 citations